HIF1A and prostate cancer: Chetomin disrupts the structure of CH1 domain of p300, which is required for its association with HIF-1, thereby leading to the attenuation of hypoxia-inducible transcription and the inhibition of tumor growth in the xenograft prostate cancer model [59].